AHS Cancer Control Alberta: all 187 studies

Page 2 of 2. Open to participants first (31), then studies with results posted, then the rest; newest registration first within each.

• Tomosynthesis in Screening MammographyCompletedNCT01086241Not applicable
• A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or LymphomaTerminatedNCT01065805Phase 1/2
• Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal MelanomaCompletedNCT01034787Phase 2
• A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)CompletedNCT01014065
• Metabolism of Lipids in Advanced CancerTerminatedNCT00962234
• Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging BoneTerminatedNCT00922519
• Hypofractionated Radiotherapy for Limited Stage Small Cell Lung CancerCompletedNCT00907569Phase 2
• Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung CancerCompletedNCT00888823Phase 1/2
• Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 ComponentsStatus unknownNCT00813787
• The Effects of Exercise Training on the Health-related Fitness of Colon Cancer SurvivorsCompletedNCT00813540Phase 2/3
• A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast CancerTerminatedNCT00771381Phase 2
• Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapyStatus unknownNCT00765986
• A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZAWithdrawnNCT00756691
• Magnetic Resonance (MR) Spectroscopy in Localized Prostate CancerCompletedNCT00756392Not applicable
• A Phase II Study to Assess Acute Toxicity and Quality of Life of Patients With Carcinoma of the Anal Canal Receiving Chemotherapy and Radiation Using Helical TomotherapyStatus unknownNCT00754078Phase 2
• Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer PatientsCompletedNCT00705094
• Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed GlioblastomaWithdrawnNCT00703859Phase 1
• Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory GatingStatus unknownNCT00690963Phase 1/2
• Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and BiomarkersCompletedNCT00676286Phase 1
• Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung CancerCompletedNCT00643396Phase 2
• Quantifying Lung Tumor Movement Under Deep Inspiration Breath HoldsCompletedNCT00643370
• SU011248 for Platinum-Refractory Urothelial Cancer Evaluation TrialCompletedNCT00578526Phase 2
• A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid TumoursCompletedNCT00566410Phase 1
• Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation TherapyTerminatedNCT00563407
• PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary MalignancyCompletedNCT00530283
• FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell LymphomaCompletedNCT00530179Not applicable
• Blood Test to Measure DNA Damage in BloodTerminatedNCT00523471
• Alberta Physical Activity and Breast Cancer Prevention (ALPHA) TrialCompletedNCT00522262Not applicable
• A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce XerostomiaStatus unknownNCT00497406Not applicable
• Aerobic Capacity and Body Composition in Colon Cancer PatientsCompletedNCT00470782
• Hypofractionated Radiotherapy for Small Cell Lung CancerCompletedNCT00469222Phase 1
• Tomotherapy Treatment for MesotheliomaCompletedNCT00469196Phase 2
• Cone Beam CT Scanning in Lung and Bladder Cancer.CompletedNCT00469066
• The Feasibility of Physical Activity in Advanced Cancer PatientsCompletedNCT00438620
• An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside AnalogsTerminatedNCT00414570Early Phase 1
• Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHLWithdrawnNCT00414089Phase 2
• The Utility of FDG-PET for Radiation Treatment in NSCLCStatus unknownNCT00385164
• Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/ChemotherapyCompletedNCT00375921
• Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation TherapyWithdrawnNCT00375700Not applicable
• Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer PatientsCompletedNCT00375180
• Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast CancerTerminatedNCT00358098
• Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung TumoursCompletedNCT00351962Not applicable
• Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in OutpatientsTerminatedNCT00351715Phase 2
• Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging TechnologyStatus unknownNCT00330109Not applicable
• [18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine TumoursTerminatedNCT00323076Phase 1/2
• A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's LymphomaCompletedNCT00322985Phase 2
• Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External ProbeCompletedNCT00314535
• Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External ProbeCompletedNCT00314522
• Development of Magnetic Resonance (MR) Simulation for Treatment PlanningCompletedNCT00314496
• Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer InstituteCompletedNCT00314470
• Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate CancerCompletedNCT00310479Not applicable
• Pulse Sequence Development on 3T Magnetic Resonance Imaging/SpectroscopyCompletedNCT00309504
• Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast CarcinomaTerminatedNCT00291304Phase 2
• A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate CancerCompletedNCT00271687Phase 2
• Study of Glutamine as Prophylaxis for Irinotecan Induced DiarrheaCompletedNCT00255229Phase 2
• Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and TemozolomideCompletedNCT00250211Phase 1/2
• Trial of Combined Aerobic and Resistance Exercise in Breast Cancer SurvivorsCompletedNCT00249015Phase 3
• MVCT Imaging Pilot Study Using Helical TomotherapyCompletedNCT00168142
• Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a ProcedureCompletedNCT00168116Phase 2
• Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.CompletedNCT00156806Phase 3
• Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)CompletedNCT00137488
• Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland FunctionCompletedNCT00137475Phase 1/2
• An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer TreatmentTerminatedNCT00131612
• Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon CancerStatus unknownNCT00131599
• Cisplatin, Carboplatin, and Oxaliplatin Interactions With Plasma ProteinsTerminatedNCT00131586
• Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic CorrelatesTerminatedNCT00130936Phase 1/2
• Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung CancerCompletedNCT00129012Phase 1
• Study of Tomotherapy in Patients With Benign Brain TumourCompletedNCT00128986Phase 1
• Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant TherapyCompletedNCT00127816Not applicable
• Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer TreatmentTerminatedNCT00126867
• High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy ImplantationCompletedNCT00126854Not applicable
• Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung CancerCompletedNCT00126828Phase 1/2
• Mathematical Modeling Analysis of Serum Prostate Specific Antigen After RadiotherapyCompletedNCT00126815
• The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate CancerStatus unknownNCT00126802Phase 1/2
• Comparative 2-D Tumor Analysis in Familial GliomasCompletedNCT00125710
• Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing RadiotherapyCompletedNCT00125697
• Sublingual Methadone for the Management of Cancer Breakthrough PainCompletedNCT00125294Phase 1
• Megavoltage CT (MVCT) Imaging for Intracavitary Radiation Treatment in Cervix CancerCompletedNCT00124423
• Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal ManipulationCompletedNCT00124410
• Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With RadiotherapyWithdrawnNCT00123812
• Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary DissectionTerminatedNCT00123799Phase 2
• Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue SarcomaTerminatedNCT00123786Phase 2
• Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low IncidenceCompletedNCT00123773Phase 2
• Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected CancerCompletedNCT00123760Phase 2/3
• Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung CancerCompletedNCT00123747Phase 2
• Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate CancerTerminatedNCT00122265
• A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck CancersStatus unknownNCT00122239

← AHS Cancer Control Alberta overview and focus areas